CDC Responds: Update on Options for Preventive Treatment for Persons at Risk for Inhalational Anthrax December 21, 2001
| Title |  PDF |
 Real Audio |
 Word |
 PowerPoint |
|---|---|---|---|---|
| CDC Responds: Update on Options for Preventive Treatment for Persons at Risk for Inhalational Anthrax December 21, 2001 | Transcript in PDF (198 KB/21 pages) | Watch the webcast | ||
| Opening statements: Jim Hughes | PDF (548 KB/2 pages) | Word (23 KB/2 pages) | ||
| Speaker 1: Brad Perkins --- Rationale for 3 treatment options (including antibiotic efficacy and vaccine efficacy) | PDF (556 KB/16 pages) | PowerPoint (1.79 MB/16 slides) | ||
| Speaker 2: Jai Lingappa --- Explanation and protocol for Anthrax vaccine option (including IND, and consent issues) | PDF (268 KB/12 pages) | PowerPoint (1.79 MB/12 slides) | ||
| Speaker 3: Nancy Rosenstein --- Adherence and adverse events associated with post-exposure chemoprophylaxis | PDF (345 KB/14 pages) | PowerPoint (214 KB/14 slides) | ||
| Speaker 4: Julie Gerberding --- Summary of treatment options (what we do/do not know) | PDF (399 KB/16 pages) | PowerPoint (189 KB/16 slides) |
- Page last updated December 21, 2001
Get email updates
To receive email updates about this page, enter your email address:
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348
24 Hours/Every Day - cdcinfo@cdc.gov
